PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services Apr 9, 2021
MINDCURE Announces Additional Equity Investment in ATMA; Kelsey Ramsden Named to ATMA Board of Directors Apr 8, 2021
MINDCURE Files Provisional Patent Application For iSTRYM, its Digital Therapeutics (DTx) SaaS Platform Mar 31, 2021